Gossamer Bio, Inc. GOSS · Insights

website

162

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercial...

Price10.645

Market Cap65.14 M

Float5.37 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Key Dates & Timelines

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro

Financial Transactions

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro